LOGOLOGOLOGOLOGO
  • About us
    • What we do
    • Who we are
      • Governance
      • Staff
      • Vacancies
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Patient BioForum
      • Study – Impact of the EU’s General Pharmaceutical Legislation
    • Industrial Biotechnology Council
      • EFIB
      • Microorganisms
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
      • Biotechnology in our Lives
  • Activities
    • 25 Years of Innovation
    • The EU Biotech Act
    • European Biotech Week
    • EU Projects
      • PRIMED Project
      • APROVALS Project
  • News & Events
    • News
    • Events
  • Library
Become a member
✕

Biomanufacturing: Europe’s Industrial Future

06/02/2025

PAPER

Brussels, 6 February 2025 - Industry across sectors face challenges in reducing the environmental footprint whilst staying competitive. Biomanufacturing is expanding its impact on different industries by providing new sustainable technologies supported by more resilient supply-chains. 

A global race is underway to produce innovative and scalable products that will change the current outlook for the health, chemical or food industries, so Europe is on an industrial edge.

The forthcoming EU Biotech Act, together with cluster of initiatives linked to biotechnology including the Bioeconomy Strategy, EU Life Sciences Strategy, Critical Medicines Act and Clean Industrial Deal, will need to deliver a strategic vision for biomanufacturing and its future in Europe as part of a comprehensive and holistic industrial policy.

This paper “Biomanufacturing: Europe’s Industrial Future”, explores the current status and future options and opportunities for biomanufacturing in Europe, underpinned by data and examples. It explores the industrial challenges and potential solutions.

Biomanufacturing: Europe's Industrial Future


Download
Share
Adrian Lincoln
Adrian Lincoln

Related posts

30/09/2025

Public Consultation Response to the European Commission’s 28th Regime proposal


Read more
14/07/2025

EuropaBio Annual Report 2025


Read more
11/07/2025

Industrial Decarbonisation Accelerator Act – EuropaBio Position


Read more

Important links

  • Public Consultation Response to the European Commission’s 28th Regime proposal
  • EuropaBio Annual Report 2025

Categories in our Newsroom

EBIO-white

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2025 Europabio. All Rights Reserved. Designed by EYAS
Become a member

Vitamin B2

The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

Insulin

Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.

Detergents

Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

Clothes

Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

Algal Omega 3

Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

Cheese

Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.